Saranas is a leading brand that offers the Early Bird® Bleed Monitoring Device, the first and only FDA-approved system for peri and post-procedural monitoring of endovascular and heart valve replacement procedures. This innovative device is designed to detect bleeds early and provide accurate and actionable information to healthcare professionals, helping to prevent complications and improve patient outcomes. Femoral access site bleeding complications can be a challenge, impacting recovery, patient satisfaction, and the overall cost of care.

The Early Bird Bleed Monitoring System integrates seamlessly into standard workflow, allowing healthcare professionals to detect and impede the progression of bleeds before they become complications. This helps to minimize the risks associated with bleeding, such as increased mortality and incremental costs. The Early Bird is ideal for a range of procedures, including Mechanical Circulatory Support, TAVR, Complex PCI/CTO, Neurovascular, and EVAR/TEVAR.

It is also suitable for patients with prior bleeding incidents or those unable or unwilling to undergo transfusion. With Saranas and the Early Bird Bleed Monitoring Device, healthcare professionals can protect outcomes and improve patient care